Co-op, Financial Planning & Analysis: January- June 2027 (Hybrid)
Insulet Corporation
Summary
Position Dates: January 11, 2027 – June 30, 2027
Job description
Position Overview: This co-op position participant roles include financial accounting and analysis, and commercial finance.
Responsibilities
- Support financial planning and analysis functions related to budgeting/forecasting.
- Support the Accounting Team with month-end close processes such as accruals, prepaids, expense tracking.
- Assist with operationalizing SAC system for forecasting and reporting purposes within the Commercial finance team
- Participate in projects and perform duties within the Finance function as assigned.
- Other projects as periodically assigned.
- Assist with sales reporting and analysis.
- Other common tasks include analysis of financial questions and problems (i.e. Regression and Trend Analysis), problem solving, active business partnering and developing innovative methods to improve job metrics and processes.
Education and Experience
Minimum Requirements:
- Currently enrolled in a Bachelor's degree program in finance or accounting (at least 2 years of completed college courses).
Preferred Skills & Competencies:
- Strong communication, presence, and relationship building skills.
- Self-motivated, high energy, respectful, honest, hard-working and loyal team player.
- Attention to detail and high level of accuracy.
- Willingness to learn.
Requirements
- Currently enrolled in a Bachelor's degree program in finance or accounting (at least 2 years of completed college courses).
- Strong communication, presence, and relationship building skills.
- Self-motivated, high energy, respectful, honest, hard-working and loyal team player.
- Attention to detail and high level of accuracy.
- Willingness to learn.
Benefits
- Medical insurance
- Holiday pay
- Sick time off
- Employee wellness programs
Company overview
Insulet Corporation (NASDAQ: PODD) is an innovative medical device company headquartered in Acton, Massachusetts, founded in 2000 with a mission to improve the lives of people with diabetes. The company specializes in developing, manufacturing, and marketing the revolutionary Omnipod Insulin Management System, which provides a unique alternative to traditional insulin delivery methods. The Omnipod system features a tubeless, disposable wearable Pod that delivers up to three days of continuous insulin without the need for needles or tubing. Insulet's flagship product, the Omnipod 5 Automated Insulin Delivery System, integrates with continuous glucose monitors to manage blood sugar levels automatically, eliminating multiple daily injections and fingersticks. With operations spanning 25 countries across North America, Europe, the Middle East, and Asia Pacific, Insulet has established itself as a global leader in diabetes management technology. The company employs between 1,001-5,000 professionals dedicated to advancing diabetes care through innovative medical device solutions.